Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine

European Journal of Pharmacology

Volumn 727, Issue 1, 2014, Pages 125-129

  Downey, Luke A ^a,b   Loftis, Jennifer M ^c,d,e  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

34 Methylenedioxy N methylamphetamine (MDMA); Bioenergetics; Inflammation; Methamphetamine; Neurodegenerative diseases; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AUTACOID; CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ANIMAL; BRAIN; COMPLICATION; DRUG ABUSE; DRUG EFFECTS; ENERGY METABOLISM; HUMAN; IMMUNOLOGY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RECURRENT DISEASE; SUBSTANCE WITHDRAWAL SYNDROME;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; ENERGY METABOLISM; HUMANS; INFLAMMATION MEDIATORS; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXIDATIVE STRESS; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84893688615     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.032     Document Type: Review

References (66)

1. P.M. Abdul Muneer, S. Alikunju, A.M. Szlachetka, and J. Haorah Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine PLoS One 6 2011 e19258
2. P.M. Abdul Muneer, S. Alikunju, A.M. Szlachetka, L.C. Murrin, and J. Haorah Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction Mol. Neurodegener. 6 2011 23
3. E. Aharonovich, E. Nunes, and D. Hasin Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment Drug Alcohol Depend. 71 2003 207 211
4. S.M. Berman, B. Voytek, M.A. Mandelkern, B.D. Hassid, A. Isaacson, J. Monterosso, K. Miotto, W. Ling, and E.D. London Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse Mol. Psychiatry 13 2008 897 908
5. O.G. Bosch, M. Wagner, F. Jessen, K.U. Kuhn, A. Joe, E. Seifritz, W. Maier, H.J. Biersack, and B.B. Quednow Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users PLoS One 8 2013 e61234
6. S.C. Bowden, F.T. Crews, M.E. Bates, W. Fals-Stewart, and M.L. Ambrose Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery Alcohol Clin. Exp. Res. 25 2001 317 321
7. M. Brownlee, H. Vlassara, and A. Cerami Nonenzymatic glycosylation and the pathogenesis of diabetic complications Ann. Intern. Med. 101 1984 527 537
8. R. Buchert, J. Obrocki, R. Thomasius, O. Vaterlein, K. Petersen, L. Jenicke, K.H. Bohuslavizki, and M. Clausen Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET Nucl. Med. Commun. 22 2001 889 897
9. J.P. Capela, H. Carmo, F. Remiao, M.L. Bastos, A. Meisel, and F. Carvalho Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview Mol. Neurobiol. 39 2009 210 271
10. M. Carvalho, H. Carmo, V.M. Costa, J.P. Capela, H. Pontes, F. Remiao, F. Carvalho, and L. Bastos Mde Toxicity of amphetamines: an update Arch. Toxicol. 86 2012 1167 1231
11. L. Chang, D. Alicata, T. Ernst, and N. Volkow Structural and metabolic brain changes in the striatum associated with methamphetamine abuse Addiction 102 Suppl. 1 2007 S16 S32
12. Chen, P.H.; Huang, M.C.; Lai, Y.C.; Chen, P.Y.; Liu, H.C.; 2012. Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal. Addict. Biol. [Epub ahead of print] PubMed PMID: 22458544.
13. J.F. Cubells, S. Rayport, G. Rajendran, and D. Sulzer Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress J. Neurosci. 14 1994 2260 2271
14. A.S. Darvesh, and G.A. Gudelsky The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats Neurotoxicol. Teratol. 26 2004 571 577
15. A.S. Darvesh, M. Shankaran, and G.A. Gudelsky 3,4- Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain J. Pharmacol. Exp. Ther. 301 2002 138 144
16. T.J. Dickerson, N. Yamamoto, D.I. Ruiz, and K.D. Janda Immunological consequences of methamphetamine protein glycation J. Am. Chem. Soc. 126 2004 11446 11447
17. D.M. Friend, J.H. Son, K.A. Keefe, and A.N. Fricks-Gleason Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity J. Pharmacol. Exp. Ther. 344 2013 511 521
18. M. Galinanes, and B.M. Matata Protein nitration is predominantly mediated by a peroxynitrite-dependent pathway in cultured human leucocytes Biochem. J. 367 2002 467 473
19. E. Gouzoulis-Mayfrank, M. Schreckenberger, O. Sabri, C. Arning, B. Thelen, M. Spitzer, K.A. Kovar, L. Hermle, U. Bull, and H. Sass Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG Neuropsychopharmacology 20 1999 565 581
20. D.G. Graham Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol. Pharmacol. 14 1978 633 643
21. J.B. Gramsbergen, and P. Cumming Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4- methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats Neurochem. Int. 51 2007 8 15
22. B. Halliwell Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97 2006 1634 1658
23. A.M. Hemmerle, J.W. Dickerson, N.R. Herring, T.L. Schaefer, C.V. Vorhees, M.T. Williams, and B. Seroogy (±)3,4 methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain J. Comp. Neurol. 520 2012 2459 2474
24. M. Huckans, A. Buenafe, J. Huan, A.A. Vandenbark, and J.M. Loftis Methamphetamine addiction is associated with increased T-cell immunoreactivity and neuropsychiatric impairment Brain, Behavior, and Immunity 26 Supp 1 2012 S25 S26
25. S.W. In, E.W. Son, D.K. Rhee, and S. Pyo Modulation of murine macrophage function by methamphetamine J Toxicol Environ Health A 67 2004 1923 1937
26. S.W. In, E.W. Son, D.K. Rhee, and S. Pyo Methamphetamine administration produces immunomodulation in mice J Toxicol Environ Health A 68 2005 2133 2145
27. A. Kaizaki, S. Tanaka, K. Tsujikawa, S. Numazawa, and T. Yoshida Recreational drugs, 3,4-Methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and diphenylprolinol, inhibit neurite outgrowth in PC12 cells J. Toxicol. Sci. 35 2010 375 381
28. Y.T. Kim, S.W. Lee, D.H. Kwon, J.H. Seo, B.C. Ahn, and J. Lee Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers J. Psychiatr. Res. 43 2009 1166 1170
29. S.J. Kish, J. Lerch, Y. Furukawa, J. Tong, T. McCluskey, D. Wilkins, S. Houle, J. Meyer, E. Mundo, and A.A. Wilson Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C] DASB and structural brain imaging study Brain 133 2010 1779 1797
30. S.M. Kousik, T.C. Napier, and P.M. Carvey The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation Front. Pharmacol. 3 2012 121
31. H. Liang, X. Wang, H. Chen, L. Song, L. Ye, and S.H. Wang et al. Methamphetamine enhances HIV infection of macrophages Am J Pathol 172 2008 1617 1624
32. J.M. Loftis, D. Choi, W. Hoffman, and M.S. Huckans Methamphetamine causes persistent immune dysregulation: a cross-species, translational report Neurotox. Res. 20 2011 59 68
33. J.M. Loftis, and M. Huckans Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy Pharmacol. Ther. 139 2013 289 300
34. J.M. Loftis, and A. Janowsky Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal J. Neurochem. 75 2000 2040 2050
35. L.R. Martinez, M.R. Mihu, A. Gacser, L. Santambrogio, and J.D. Nosanchuk Methamphetamine enhances histoplasmosis by immunosuppression of the host J Infect Dis 200 2009 131 141
36. B.M. Matata, and M. Galinanes Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity J. Biol. Chem. 277 2002 2330 2335
37. G. Matarese, C. Procaccini, and V. De Rosa The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J. Leukoc. Biol. 84 2008 893 899
38. U.D. McCann, Z. Szabo, M. Vranesic, M. Palermo, W.B. Mathews, H.T. Ravert, R.F. Dannals, and G.A. Ricaurte Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±) 3, 4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance Psychopharmacology 200 2008 439 450
39. National Institutes of Health, National Institute on Drug Abuse. Substance Use Disorders and Molecular Regulation of Brain Energy Utilization. 2013. http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-005.html.
40. J. Obrocki, A. Schmoldt, R. Buchert, B. Andresen, K. Petersen, and R. Thomasius Specific neurotoxicity of chronic use of ecstasy Toxicol. Lett. 127 2002 285 297
41. R. Pachmerhiwala, N. Bhide, M. Straiko, and G.A. Gudelsky Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain Eur. J. Pharmacol. 644 2010 67 72
42. A.C. Parrott MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress J. Psychopharmacol. 20 2006 147 163
43. Peraile, I.; Granado, N.; Torres, E.; Gutierrez-Lopez, M.D.; Moratalla, R.; Colado, M.I.; Shea, E.; 2013. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders. Psychopharmacol. (Berl.).
44. K. Permpoonputtana, and P. Govitrapong The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines Neurotox. Res. 23 2013 189 199
45. A. Potter, L. Downey, and C. Stough Cognitive function in ecstasy naive abstinent drug dependants and MDMA users Curr. Drug Abuse Rev. 6 2013 71 76
46. R. Potula, B.J. Hawkins, J.M. Cenna, S. Fan, H. Dykstra, S.H. Ramirez, B. Morsey, M.R. Brodie, and Y. Persidsky Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment J. Immunol. 185 2010 2867 2876
47. D. Pubill, C. Chipana, A. Camins, M. Pallàs, J. Camarasa, and E. Escubedo Free radical production induced by methamphetamine in rat striatal synaptosomes Toxicol. Appl. Pharmacol. 204 2005 57 68
48. M.S. Quinton, and B.K. Yamamoto Causes and consequences of methamphetamine and MDMA toxicity AAPS J. 8 2006 E337 E347
49. C. Ros-Simo, M. Moscoso-Castro, J. Ruiz-Medina, J. Ros, and O. Valverde Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3, 4-Methylenedioxymethamphetamine (MDMA) in mice J. Neurochem. 125 2013 736 746
50. J.R. Sadek, O. Vigil, I. Grant, and R.K. Heaton The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence J. Clin. Exp. Neuropsychol. 29 2007 266 276
51. N. Sailasuta, O. Abulseoud, K.C. Harris, and B.D. Ross Glial dysfunction in abstinent methamphetamine abusers J. Cereb. Blood Flow Metab. 30 2010 950 960
52. T.L. Schaefer, C.E. Grace, A.A. Braun, R.M. Amos-Kroohs, D.L. Graham, M.R. Skelton, M.T. Williams, and C.V. Vorhees Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA Int. J. Neuropsychopharmacol. 16 2013 1383 1394
53. Y. Sekine, Y. Ouchi, G. Sugihara, N. Takei, E. Yoshikawa, K. Nakamura, Y. Iwata, K.J. Tsuchiya, S. Suda, K. Suzuki, M. Kawai, K. Takebayashi, S. Yamamoto, H. Matsuzaki, T. Ueki, N. Mori, M.S. Gold, and J.L. Cadet Methamphetamine causes microglial activation in the brains of human abusers J. Neurosci. 28 2008 5756 5761
54. J.A. Siegel, B.S. Park, and J. Raber Methamphetamine exposure during brain development alters the brain acetylcholine system in adolescent mice J. Neurochem. 119 2011 89 99
55. M.R. Skelton, M.T. Williams, and C.V. Vorhees Developmental effects of 3,4 methylenedioxymethamphetamine: a review Behav. Pharmacol. 19 2008 91 111
56. B.J. Song, K.H. Moon, V.V. Upreti, N.D. Eddington, and I.J. Lee Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage Curr. Pharm. Biotechnol. 11 2010 434 443
57. P.M. Thompson, K.M. Hayashi, S.L. Simon, J.A. Geaga, M.S. Hong, Y. Sui, J.Y. Lee, A.W. Toga, W. Ling, and E.D. London Structural abnormalities in the brains of human subjects who use methamphetamine J. Neurosci. 24 2004 6028 6036
58. E. Torres, M.D. Gutierrez-Lopez, A. Mayado, A. Rubio, E. Shea, and M.I. Colado Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity J. Neuroinflamm. 8 2011 53
59. A. Urrutia, A. Rubio-Araiz, M.D. Gutierrez-Lopez, A. ElAli, D.M. Hermann, E. Shea, and M.I. Colado A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine Neurobiol. Dis. 50 2013 49 58
60. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, C. Wong, and J. Logan Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers Am. J. Psychiatry 158 2001 383 389
61. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382
62. N.D. Volkow, J.S. Fowler, and G.J. Wang The addicted human brain: insights from imaging studies J. Clin. Invest. 111 2003 1444 1451
63. B.K. Yamamoto, and M.G. Bankson Amphetamine neurotoxicity: cause and consequence of oxidative stress Crit. Rev. Neurobiol. 17 2005 87 117
64. B.K. Yamamoto, and J. Raudensky The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse J. Neuroimmune Pharmacol. 3 2008 203 217
65. L. Ye, J.S. Peng, X. Wang, Y.J. Wang, G.X. Luo, and W.Z. Ho Methamphetamine enhances Hepatitis C virus replication in human hepatocytes J Viral Hepat 15 2008 261 270
66. D.G. Zuloaga, J.A. Siegel, S.F. Acevedo, M. Agam, and J. Raber Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins Dev. Neurosci. 35 2013 338 346